Measurement of serum prostate cancer markers using a nanopore thin film based optofluidic chip
- 1 March 2016
- journal article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 77, 491-498
Abstract
No abstract availableKeywords
Funding Information
- NSF (ECCS 0845370)
- NSF-Pfund
- NIH (R01CA096534)
This publication has 26 references indexed in Scilit:
- Active surveillance for low-risk prostate cancerCritical Reviews in Oncology/Hematology, 2013
- Fluorescence Detection and Imaging of Biomolecules Using the Micropatterned Nanostructured Aluminum OxideLangmuir, 2013
- Nanostructured optical microchips for cancer biomarker detectionBiosensors and Bioelectronics, 2012
- A polymer nanostructured Fabry–Perot interferometer based biosensorBiosensors and Bioelectronics, 2011
- Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection BiomarkersJournal of Urology, 2011
- Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate‐specific antigenCancer, 2010
- Analytical Validation of Protein-Based Multiplex Assays: A Workshop Report by the NCI-FDA Interagency Oncology Task Force on Molecular DiagnosticsClinical Chemistry, 2010
- Progression of Prostate Cancer Despite an Extremely Low Serum Level of Prostate-Specific AntigenKorean Journal of Urology, 2010
- Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancerCurrent Opinion in Urology, 2009
- The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostateThe Prostate, 1992